Regulatory, payer KOLs to inform Gilde investment decisions
Council led by former EMA Executive Director Guido Rasi
Gilde is aiming to embed better regulatory and reimbursement decision-making into its investments and portfolio companies via the establishment of an advisory council led by some of the biggest names in the sector.
Gilde Healthcare Partners’ Impact Council is populated with top-tier regulatory specialists, payer and HTA experts and patient advocates, with the headline being the group’s chair: Professor Guido Rasi, former executive director of EMA...